Descemet Stripping Only for Fuchs Endothelial Corneal Dystrophy: Will It Become the Gold Standard?
Kathryn Colby
Abstract
ABSTRACT: Descemet stripping only (DSO) has become a viable treatment option for certain cases of Fuchs Endothelial Corneal Dystrophy (FECD). This article describes the history of the development of DSO, its current status, and what successful DSO tells us about the pathophysiology of FECD. Remaining questions and future directions are also highlighted.
Topics & Concepts
Stripping (fiber)OphthalmologyGold standard (test)Corneal dystrophyCorneaMedicineDystrophyInternal medicinePathologyEngineeringElectrical engineeringCorneal surgery and disordersGlaucoma and retinal disordersCorneal Surgery and Treatments